...
首页> 外文期刊>Journal of Clinical Microbiology >Development of a rapid enzyme immunoassay for Clostridium difficile toxin A and its use in the diagnosis of C. difficile-associated disease.
【24h】

Development of a rapid enzyme immunoassay for Clostridium difficile toxin A and its use in the diagnosis of C. difficile-associated disease.

机译:艰难梭菌毒素A快速酶免疫测定方法的开发及其在艰难梭菌相关疾病诊断中的应用。

获取原文
           

摘要

A rapid (2.5 h) direct enzyme immunoassay (EIA) for Clostridium difficile toxin A was developed for clinical use. Specimen centrifugation and filtration were not required. The EIA detected toxin A levels in patient stool as low as 20 pg (2 ng/ml of stool). The test was 5,000 times more sensitive for toxin A than it was for toxin B and did not react with a panel of other bacterial species with the exception of one highly toxigenic strain of Clostridium sordellii. The EIA was compared with the cytotoxin assay, culture of toxigenic C. difficile (toxigenic culture), and latex agglutination by using 313 fresh stool specimens submitted from patients with suspected C. difficile-associated disease. Results read visually and with a plate reader were similar. Sixty-two specimens were positive by one or more tests, but only 22 (35%) were positive by all four laboratory methods. The EIA was 84.1% sensitive and 98.9% specific when it was compared with the cytotoxin assay. The use of toxigenic culture to referee discrepant results (EIA versus cytotoxin assay) showed the EIA sensitivity and specificity to be 95.1 and 99.3%, respectively, with respect to other laboratory methods. Patient charts were reviewed for antibiotic-associated diarrhea on 108 specimens, including all those that were positive by at least one test method. Of 34 patients determined to have C. difficile-associated disease, 29 (85.3%) were positive by EIA, 32 (94.1%) were positive by the cytotoxin assay, 27 (79.4%) were positive by toxigenic culture, and 20 (58.8%) were positive by latex agglutination. Seven patients with antibiotic-associated diarrhea had a positive latex result, but results were negative by EIA, the cytotoxin assay, and toxigenic culture. The EIA demonstrated high specificity and good sensitivity for C. difficile-associated disease cases. The test can be used alone or in combination with the cytotoxin assay or toxigenic culture to provide rapid and sensitive results.
机译:已开发出一种用于艰难梭菌毒素A的快速(2.5 h)直接酶免疫测定(EIA)的临床应用。不需要样品离心和过滤。 EIA检测到患者粪便中的毒素A水平低至20 pg(2 ng / ml粪便)。该测试对毒素A的敏感度比对毒素B的敏感度高5,000倍,并且除一种索氏梭状芽孢杆菌的高产毒菌株外,不与其他细菌种类反应。通过使用疑似艰难梭菌相关疾病患者提交的313份新鲜粪便标本,将EIA与细胞毒素检测,产毒性艰难梭菌培养(产毒素培养)和乳胶凝集进行了比较。目测和用酶标仪读取的结果相似。通过一项或多项测试,有62份标本呈阳性,但通过所有四种实验室方法,只有22份(35%)呈阳性。与细胞毒素测定法相比,EIA敏感度为84.1%,特异性为98.9%。相对于其他实验室方法,使用毒物培养物确定的裁判结果不一致(EIA与细胞毒素测定)表明,EIA敏感性和特异性分别为95.1%和99.3%。回顾了108个标本的患者病历表中与抗生素相关的腹泻,包括所有通过至少一种测试方法阳性的标本。在确定患有艰难梭菌相关疾病的34位患者中,EIA阳性29例(85.3%),细胞毒素测定阳性32例(94.1%),产毒培养阳性27例(79.4%),20例(58.8)胶乳凝集呈阳性。 7例抗生素相关性腹泻患者的乳胶结果为阳性,但通过EIA,细胞毒素测定和产毒培养的结果为阴性。 EIA对艰难梭菌相关疾病病例显示出高特异性和良好的敏感性。该测试可单独使用,也可与细胞毒素测定法或产毒培养物结合使用,以提供快速而灵敏的结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号